Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Notes Payables (2021 - 2025)

IM Cannabis has reported Notes Payables over the past 5 years, most recently at $10.3 million for Q4 2025.

  • For Q4 2025, Notes Payables fell 5.2% year-over-year to $10.3 million; the TTM value through Dec 2025 reached $10.3 million, down 5.2%, while the annual FY2025 figure was $10.3 million, 7.09% down from the prior year.
  • Notes Payables was $10.3 million for Q4 2025 at IM Cannabis, down from $10.8 million in the prior quarter.
  • Across five years, Notes Payables topped out at $10.8 million in Q4 2024 and bottomed at $6.8 million in Q4 2022.
  • The 5-year median for Notes Payables is $8.9 million (2023), against an average of $8.7 million.
  • Year-over-year, Notes Payables soared 30.69% in 2023 and then decreased 5.2% in 2025.
  • Over 5 years, Notes Payables stood at $6.9 million in 2021, then decreased by 1.13% to $6.8 million in 2022, then skyrocketed by 30.69% to $8.9 million in 2023, then grew by 21.79% to $10.8 million in 2024, then dropped by 5.2% to $10.3 million in 2025.
  • The last three reported values for Notes Payables were $10.3 million (Q4 2025), $10.8 million (Q4 2024), and $8.9 million (Q4 2023) per Business Quant data.